immunopathology Archives

Why Wearing A Non-Surgical Face Covering Makes It Worse.

25 September 2021

UK COVID-19 Mortality Rate. The most straightforward, simple and transparent measure of whether non-surgical face coverings work is that even now, over 18 months into the current insanity, the UK’s COVID-19 mortality rate is 3.27-times higher than the worldwide average (@0500UTC today, source: Johns Hopkins Coronavirus Resource Center/Worldmeters). With the worldwide average being just what […]

Antiphospholipid Antibodies And COVID-19 Vaccines.

25 August 2021

Background. As early as October 2020 – over ten months ago – we explained why a vaccine was not needed and would not be effective. That’s a vaccine using its correct medical definition, i.e. a prophylactic treatment providing long-term or lifetime protection. All of the four main treatment candidates being injected – Vaxzevria; BNT126b2; mRNA-1273 […]

Is Ivermectin Another ‘Wonderdrug’?

21 April 2021

Is This Remdesivirmania Redux? Ivermectin is the subject of increasing coverage and concomitant hysteria around it being another ‘wonderdrug’ for the treatment of SARS-CoV-2. It has been touted as a potential treatment since the days of remdesivir, chloroquine, hydroxychloroquine and lopinavir. We picked apart remdesivir in October 2020, days after it was approved by the […]

These ‘Vaccines’ Become More Dangerous By The Day.

15 April 2021

Treatments Targeting The S Protein Were Already Ineffective. We have been vehement critics of the miracle ‘wonderdrug’ antivirals (they are not vaccines) rushed onto the market in recent months. In October 2020, we first set out the difference between vaccines and antivirals and highlighted the risks in RNA/mRNA vaccine candidates: these fall into the category […]

UK Deaths Increase By Over One Third Since Vaccine Rollout.

19 February 2021

UK Deaths Increase By More Than One Third Since Vaccine Rollout. In the four weeks since the ‘vaccine’ rollout, UK COVID-19 deaths have risen by 31,368 (source: Johns Hopkins Coronavirus Resource Center and Worldmeters, @0500UTC 18/02/21). As the ‘vaccine’ is being offered to those in high risk groups first, it does not follow that over […]

Antibody-Dependent Enhancement And This Rushed ‘Vaccine’.

19 January 2021

What is Antibody-Dependent Enhancement? As we have set out previously, it takes 10-15 years to develop a vaccine. This timescale is entirely understandable and justifiable when you consider that the vaccine has to be both effective and safe. Safe includes not causing unacceptable side effects, which include the vaccine or immune system’s response triggering autoimmunity, […]

Exoribonuclease – Your Starter For Ten Mr Prime Minister.

30 December 2020

Q1. How can a virus containing an exoribonuclease mutate in the way you are saying? Coronaviruses possess an exoribonuclease within nonstructural protein 14 (nsp14-ExoN). This functions as a proofreader during viral transcription and encoding, ensuring high fidelity replication. This minimises the potential for mutation, as shown by the fact that sarbecovirus/lineage B betacoronaviruses with their […]

Avoid Any Experimental Vaccine.

6 December 2020

The Right Vaccine Can Be Good. Few would disagree – us included – that vaccines per se are a good thing. Over the decades vaccines have been created that have eradicated or allowed the prevention of truly horrible diseases such as smallpox, polio, measles, hepatitis A & B, mumps, diptheria and whooping cough. Those of […]

The Common Cold And SARS-CoV-2 Immunity.

30 November 2020

No Vaccine Required. Is it possible that the common cold could can provide immunity through memory T cells to a significant proportion of a population? In recent articles we have highlighted various other reasons why a vaccine is not required. This include; those not at risk (that’s over 99%) don’t need one and those at […]

Déjà vu – memory T cells have seen SARS-CoV-2 before.

23 November 2020

Newly-Discovered Is Not New. In early September we first highlighted the incorrect designation of SARS-CoV-2 as a ‘novel’ or ‘new’ coronavirus when it should have been designated ‘newly-discovered’. There is a subtle but fundamental difference: something that is new did not previously exist whereas something that is newly-discovered already existed but not been discovered yet. […]